Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.94
-0.02 (-0.07%)
Jun 15, 2026, 11:26 AM EDT - Market open
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.47 billion as of June 15, 2026. Its market cap has decreased by -19.93% in one year.
Market Cap
1.47B
Enterprise Value
1.06B
1-Year Change
-19.93%
Ranking
Category
Stock Price
$28.94
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.47B, a decrease of -18.03%. That is a compound annual growth rate of -3.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 1.47B | -16.07% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.54B |
| Capricor Therapeutics | 1.49B |
| Novavax | 1.46B |
| SELLAS Life Sciences Group | 1.46B |
| Vir Biotechnology | 1.45B |
| GH Research | 1.45B |
| UroGen Pharma | 1.45B |
| AtaiBeckley | 1.44B |